Lysodren

Product NDC
76336-080
11-digit product format
763360080
Labeler code
76336
Product ID
76336-080_40a4cc96-c834-c03b-e063-6394a90a01d1
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
mitotane
Dosage form
TABLET
Route
ORAL
Labeler
HRA Pharma Rare Diseases
Application
NDA016885
Marketing category
NDA
Marketing start
1978-10-15
Substance
MITOTANE
Active strength
500 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inducers [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N016885-001LYSODRENMITOTANE500MGTABLET / ORALRLD, RS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N016885-001LYSODREN500MGTABLET / ORALRLD, RS, Approved before 1982cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Lysodren
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MITOTANE500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
78E4J5IB5JInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197988Internal RxNorm lookup
207373Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
f0cd76e9-460c-450e-b094-172e636f340aAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
abe167df-4819-3241-373e-2719d5c257e6Product name120140508
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76336-080-60Lysodren100 in 1 BOTTLETABLET10015
76336-080-60Lysodren1 in 1 CARTONTABLET115

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
76336-080-60EA - Each76336-0808bc33b93-1174-4767-8a3f-b70f772d2d7812019-03-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76336-080LYSODREN (MITOTANE) TABLET [HRA PHARMA RARE DISEASES]13Current NDC, Legacy NDC, 2 package rows20250504_f0cd76e9-460c-450e-b094-172e636f340a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LysodrenMITOTANEESTEVE PHARMACEUTICALS, S.A.4046a224-8832-daa2-e063-6294a90a11d72026-03-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 016885
application number: NDA016885
LysodrenMITOTANEHRA Pharma Rare Diseasesf0cd76e9-460c-450e-b094-172e636f340a2025-10-08Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 016885
application number: NDA016885
ndc (product): 76336-080

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
207373LYSODREN 500 MG Oral TabletPSNf0cd76e9-460c-450e-b094-172e636f340a15
197988mitotane 500 MG Oral TabletPSNf0cd76e9-460c-450e-b094-172e636f340a15
207373mitotane 500 MG Oral Tablet [Lysodren]SBDf0cd76e9-460c-450e-b094-172e636f340a15
197988mitotane 500 MG Oral TabletSCDf0cd76e9-460c-450e-b094-172e636f340a15
207373Lysodren 500 MG Oral TabletSYf0cd76e9-460c-450e-b094-172e636f340a15

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
76336-080-60763360080601 BOTTLE in 1 CARTON (76336-080-60) / 100 TABLET in 1 BOTTLE1 bottle1978-10-150000-00-00NoNoCurrent